{
 "drug": "Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection",
 "asOf": "2026-10-09",
 "status": "discontinuing",
 "since": "09/09/2026",
 "dayN": 30,
 "cat": "Anti-Infective",
 "companies": [
  "Merck Sharp & Dohme LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "09/09/2026",
   "update_type": "New",
   "initial_posting_date": "09/09/2026",
   "package_ndc": "0006-3856-02",
   "generic_name": "Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection",
   "contact_info": "800-672-6372",
   "related_info": "To be discontinued on or near late September 2026.",
   "openfda": {
    "application_number": [
     "NDA212819"
    ],
    "brand_name": [
     "RECARBRIO"
    ],
    "generic_name": [
     "IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS"
    ],
    "manufacturer_name": [
     "Merck Sharp & Dohme LLC"
    ],
    "product_ndc": [
     "0006-3856"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IMIPENEM ANHYDROUS",
     "CILASTATIN",
     "RELEBACTAM ANHYDROUS"
    ],
    "rxcui": [
     "2184142",
     "2184147"
    ],
    "spl_id": [
     "11f74255-d000-4759-a561-136a5f13f667"
    ],
    "spl_set_id": [
     "be32f468-738b-40df-a425-591e12f65159"
    ],
    "package_ndc": [
     "0006-3856-01",
     "0006-3856-02"
    ],
    "nui": [
     "M0024174",
     "N0000175496",
     "N0000175513",
     "N0000175514",
     "N0000175930",
     "N0000000202"
    ],
    "pharm_class_cs": [
     "Carbapenems [CS]"
    ],
    "pharm_class_epc": [
     "Penem Antibacterial [EPC]",
     "Renal Dehydropeptidase Inhibitor [EPC]",
     "beta Lactamase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
     "Dipeptidase Inhibitors [MoA]",
     "beta Lactamase Inhibitors [MoA]"
    ],
    "unii": [
     "Q20IM7HE75",
     "141A6AMN38",
     "1OQF7TT3PF"
    ]
   },
   "update_date": "09/09/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)",
   "company_name": "Merck Sharp & Dohme LLC",
   "status": "To Be Discontinued"
  }
 ],
 "firstSeen": "2026-09-10",
 "history": [
  {
   "date": "2026-09-10",
   "kind": "new",
   "to": "discontinuing",
   "text": "Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection appeared on the FDA shortage list (being discontinued)"
  }
 ]
}